缺氧和阿尔茨海默病之间的关系:一个更新的审查
Borui Tao1,2, Wei Gong3, Chengyuan Xu1
1Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Frontiers in aging neuroscience
|August 1, 2024
概括
缺氧和氧化压力与阿尔茨海默氏症 (AD) 病原发生有关. 抗氧化剂可能为阿尔茨海默病提供潜在的治疗策略,需要进一步调查.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特征是粉样β斑块和神经纤维状结.
- 大脑的高氧需求使其易受缺氧的影响,这是AD的可疑贡献者.
- 导致缺氧,氧化应激和阿尔茨海默病的确切机制仍在研究中.
研究的目的:
- 审查缺氧诱导因素-1α (HIF-1α) 在阿尔茨海默病中的作用.
- 探索氧化应激和AD病变发生之间的联系.
- 评估抗氧化剂作为AD的潜在治疗途径.
主要方法:
- 文献综述侧重于缺氧,HIF-1α,氧化应激,以及它们与AD的关系.
- 对阿尔茨海默病的病原性因素现有证据的分析,包括Aβ沉积和炎症.
- 检查抗氧化剂的潜在保护作用.
主要成果:
- 低氧诱导因子-1α (HIF-1α) 可能在AD中发挥双重作用,有助于和潜在的保护作用.
- 氧化压力与关键的AD病理有关,例如线粒体功能障碍和粉样β沉积.
- 目前的研究表明,抗氧化剂可以抵消AD相关的病原性因素.
结论:
- 缺氧和氧化压力与阿尔茨海默病有显著的关联.
- 抗氧化剂显示出作为阿尔茨海默病潜在治疗策略的前景.
- 对阿尔茨海默病的抗氧化疗法的进一步研究是有必要的.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Hypoxia
992
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
992
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Acute Respiratory Failure-II
192
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192
Role of Neurotransmitters in Memory
499
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
499
Dementia
109
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
109


